瑞加诺生铷-82 PET心肌灌注显像中的脾脏关闭现象:临床效用的评估
本研究评估瑞加诺生诱导的脾脏关闭现象(SSO)的诊断效用。推导队列(n=100)显示脾脏摄取从静息到负荷显著下降,验证队列(n=315)中28%(SRR=0.88)和15%(视觉)被分类为脾脏无反应者,其心肌血流储备较低,且在有创冠状动脉造影中更可能发现梗阻性心外膜病变而PET扫描正常。结论认为基于视觉或定量评估SSO的脾脏反应缺失可用于识别血管扩张反应不足。
要点
- 推导队列显示瑞加诺生负荷后脾脏摄取从静息79.9±16.8 kBq·mL降至69.1±16.2 kBq·mL(P<.001)。
- 验证队列中28%(SRR=0.88)和15%(视觉)为脾脏无反应者,其MFR较低。
- 脾脏无反应者中,MFR<1.5者更常见PET正常但ICA示梗阻性心外膜病变。
核心结论
- 基于视觉或定量评估SSO的脾脏反应缺失可用于识别血管扩张反应不足。
研究设计与样本
- 连续纳入临床指征行瑞加诺生铷-82 PET-MPI的可疑冠心病患者;推导队列为无灌注缺损且MFR≥2者(n=100),验证队列为同时接受PET-MPI和有创冠状动脉造影者(n=315)。
主要发现
- 推导队列(n=100,年龄57.4±11.6岁,女性77%)脾脏摄取从静息79.9±16.8 kBq·mL降至负荷69.1±16.2 kBq·mL(P<.001)。
- 验证队列(n=315,年龄66.3±10.4岁,男性67%)中28%(SRR=0.88)和15%(视觉)被分类为脾脏无反应者。
- 无反应者MFR较低:SRR法1.55±0.65 vs 1.76±0.78(P=.02),视觉法1.18±0.33 vs 1.79±0.77(P<.001)。
- 基于ICA,无反应者更常见PET扫描正常但存在梗阻性心外膜病变,尤其在MFR<1.5者中:SRR法61% vs 34%(P=.05),视觉法68% vs 33%(P=.01)。
关键数值与推荐
- 脾脏反应比(SRR)=0.88作为定量分类脾脏无反应者的阈值。
- 视觉评估亦用于分类脾脏无反应者。
临床怎么用
- 原文结论指出,基于视觉或定量评估SSO的脾脏反应缺失可用于识别血管扩张反应不足。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Splenic switch-off (SSO) is a phenomenon describing a decrease in splenic radiotracer uptake after vasodilatory stress. We aimed to assess the diagnostic utility of regadenoson-induced SSO. METHODS: We included consecutive patients who had clinically indicated Regadenoson Rb-82 PET-MPI for suspected CAD. This derivation cohort (no perfusion defects and myocardial flow reserves (MFR) ≥ 2) was used to calculate the splenic response ratio (SRR). The validation cohort was defined as patients who underwent both PET-MPI studies and invasive coronary angiography (ICA). RESULTS: The derivation cohort (n = 100, 57.4 ± 11.6 years, 77% female) showed a decrease in splenic uptake from rest to stress (79.9 ± 16.8 kBq⋅mL vs 69.1 ± 16.2 kBq⋅mL, P < .001). From the validation cohort (n = 315, 66.3 ± 10.4 years, 67% male), 28% (via SRR = 0.88) and 15% (visually) were classified as splenic non-responders. MFR was lower in non-responders (SRR; 1.55 ± 0.65 vs 1.76 ± 0.78, P = .02 and visually; 1.18 ± 0.33 vs 1.79 ± 0.77, P < .001). Based on ICA, non-responders were more likely to note obstructive epicardial disease with normal PET scans especially in patients with MFR < 1.5 (SRR; 61% vs 34% P = .05 and visually; 68% vs 33%, P = .01). CONCLUSION: Lack of splenic response based on visual or quantitative assessment of SSO may be used to identify an inadequate vasodilatory response.
引用
- Saad JM, Ahmed AI, Han Y, et al. Splenic switch-off in regadenoson 82Rb-PET myocardial perfusion imaging: assessment of clinical utility. J Nucl Cardiol. 2023. PMID: 36607537. doi:10.1007/s12350-022-03158-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。